Moderna says its Covid-19 vaccine was well-tolerated and generated robust immune response in children ages 6 to 11
By Jamie Gumbrecht, CNN Interim results of a Phase 2/3 trial showed Moderna’s Covid-19 vaccine was well-tolerated and generated a robust immune…
Continue Reading